Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$2.45
-5.23%
Mkt Cap $294.89M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (24 analysts)
$5.63
Range $3.50 – $8.00
Implied Upside
+130.3%
Consensus $5.63 vs current $2.45
NASDAQ·Healthcare·Biotechnology
$2.45
-5.23%
Mkt Cap $294.89M
Buy
4
Hold
1
Sell
0
Price Target (24 analysts)
$5.63
Range $3.50 – $8.00
+130.3%
Consensus $5.63 vs current $2.45